Zirabev 400mg Injection (Bevacizumab) – Imported

Zirabev 400mg Injection contains Bevacizumab, a monoclonal antibody used in the treatment of several types of cancer. It works by targeting vascular endothelial growth factor (VEGF), a protein involved in the formation of new blood vessels that can support tumor growth. Zirabev is administered by intravenous infusion under the supervision of a qualified healthcare professional.

Uses of Zirabev 400mg Injection

Zirabev may be used as part of combination treatment for certain cancers, depending on the approved indication and treatment protocol. Bevacizumab-containing regimens may be used for conditions such as:

• Metastatic colorectal cancer
• Certain types of non-small-cell lung cancer
• Advanced or metastatic kidney cancer
• Certain ovarian, fallopian tube, or primary peritoneal cancers
• Persistent, recurrent, or metastatic cervical cancer
• Other approved oncology indications depending on the patient’s treatment plan

Treatment selection depends on the cancer type, stage, previous therapies, and individual patient factors.

How Zirabev Works

Zirabev contains Bevacizumab, which binds to vascular endothelial growth factor (VEGF). VEGF promotes the development of new blood vessels. By inhibiting VEGF activity, Bevacizumab can reduce the formation of blood vessels that tumors may use to obtain oxygen and nutrients, thereby helping to slow tumor growth.

Administration and Dosage

Zirabev 400mg Injection is administered intravenously (IV) by a trained healthcare professional. The dosage and treatment interval depend on the specific cancer being treated and the accompanying treatment regimen.

The 400mg vial should not be considered a standard single-patient dose. Bevacizumab dosing is generally calculated according to the approved indication and patient-specific factors.

Zirabev should be prepared and administered according to the product information and the treating oncologist’s instructions. It must not be self-administered.

Possible Side Effects

Like other anticancer medicines, Zirabev can cause side effects. Possible adverse effects include:

• High blood pressure
• Fatigue and weakness
• Headache
• Diarrhea
• Nausea
• Reduced appetite
• Nosebleeds
• Protein in the urine
• Abdominal discomfort
• Infusion-related reactions

More serious complications can occur, including severe hypertension, bleeding, blood clots, gastrointestinal perforation, impaired wound healing, and kidney-related complications. Patients should receive appropriate medical monitoring during treatment.

Important Precautions

Before receiving Zirabev, patients should tell their healthcare provider about all medical conditions and medicines they use. Particular caution may be required in patients with:

• Uncontrolled high blood pressure
• A history of significant bleeding
• Recent surgery or planned surgery
• Cardiovascular or blood-clotting problems
• Kidney problems
• Conditions that may increase the risk of gastrointestinal complications

Bevacizumab can affect wound healing, so treatment timing around major surgery requires careful medical planning.

Pregnancy and Breastfeeding

Bevacizumab may cause fetal harm. Patients who are pregnant, planning to become pregnant, or breastfeeding should discuss treatment with their healthcare provider before receiving Zirabev. Appropriate contraception may be recommended during treatment and for a period after treatment, according to the prescribing information.

Storage

Zirabev should generally be stored under refrigerated conditions (2°C to 8°C) and protected from light. It should not be frozen or shaken. Proper cold-chain storage and handling are important for maintaining product quality. Always follow the storage instructions supplied with the product.

Product Information

• Product Name: Zirabev 400mg Injection
• Active Ingredient: Bevacizumab
• Strength: 400mg
• Dosage Form: Concentrate for solution for infusion
• Route: Intravenous infusion
• Pack Size: 1 vial
• Manufacturer: Zirabev / Imported
• Origin: Imported

Why Choose Zirabev 400mg Injection?

Zirabev contains Bevacizumab, a targeted anti-VEGF therapy used as part of established treatment regimens for several cancers. Its mechanism works by inhibiting VEGF signaling and reducing tumor-associated blood-vessel formation.

For oncology medicines such as Zirabev, purchase should be made through a reliable pharmaceutical supplier, with appropriate storage and cold-chain handling. Treatment should always be prescribed and supervised by a qualified oncologist.

Frequently Asked Questions

What is Zirabev 400mg Injection used for?

Zirabev contains Bevacizumab and is used in combination with other anticancer treatments for several approved cancer indications.

What is the generic name of Zirabev?

The generic name is Bevacizumab.

How is Zirabev administered?

Zirabev is administered as an intravenous infusion by a qualified healthcare professional.

Is Zirabev a chemotherapy medicine?

Zirabev is a monoclonal antibody and anti-VEGF targeted therapy rather than a traditional cytotoxic chemotherapy drug. It may be administered alongside chemotherapy in some treatment regimens.

Does Zirabev require refrigeration?

Yes. Zirabev generally requires refrigerated storage at 2°C to 8°C and should be protected from light.

Can Zirabev be used without a doctor’s prescription?

No. Zirabev is a specialist oncology medicine and should only be used under the supervision of a qualified healthcare professional.